PD 0200390 dose ranging trial: A randomized, double blind, parallel group, placebo controlled, multicenter outpatient trial of PD 0200390 in adults with primary insomnia.

Trial Profile

PD 0200390 dose ranging trial: A randomized, double blind, parallel group, placebo controlled, multicenter outpatient trial of PD 0200390 in adults with primary insomnia.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2012

At a glance

  • Drugs Atagabalin (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Jul 2012 Actual end date changed from Dec 2008 to Jan 2009 as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Actual patient numbers (682) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top